All Eyes Watching: CDC Votes to Remove Hep B Vaccines From Newborn Recommendation

BY JEFF SKINNER 

STATEWIDE - Today The Centers for Disease Control and Prevention's vaccine advisory committee voted 8-3 to remove the hepatitis b vaccine from the recommended list of vaccines to give to newborns and infants. The move changed recommendations in place for nearly 30 years that had essentially no scientific backing to establish. 

Hepatitis B is a virus that attacks the liver and is transmitted through blood and feces. It is particularly prevalent in individuals with intravenous drug usage and in the homosexual community. It has long since been a point of contention as to why, if a pregnant mother was not positive for the virus, the vaccine against said virus would be offered to the infant, particularly given the known adverse health risks associated with the vaccine. The childhood vaccine schedule in general has come under significant scrutiny since the covid era, as parents have increasingly taken a scrupulous eye to the medical establishment and learned of the damaging effects of heavy metal adjuvants, such as those contained in the hepatitis B vaccine. 

The hepatitis B vaccine contains adjuvants like Aluminum hydroxide and Formaldehyde, both toxic compounds known to increase neuroinflammation and lead to autoimmune diseases and Autism Spectrum Disorders. Comparative cohort studies have regularly showed adverse health outcomes associated with vaccines on the childhood registry, such as developmental delays, asthma, ear infections and gastrointestinal disorders do not occur in children that are unvaccinated at the same rates.

The CDC is still recommending children born to Hep B positive mothers receive the vaccine, though the ACIP voted 6-4, with one abstention, that parents of older children consider hepatitis B antibody testing before considering subsequent hepatitis B vaccination.